Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 121

1.

Herpes Simplex Virus Type 2 Acquisition Among HIV-1-Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study.

Celum C, Hong T, Cent A, Donnell D, Morrow R, Baeten JM, Firnhaber C, Grinsztejn B, Hosseinipour MC, Lalloo U, Nyirenda M, Riviere C, Sanchez J, Santos B, Supparatpinyo K, Hakim J, Kumarasamy N, Campbell TB; ACTG PEARLS/A5175 Team..

J Infect Dis. 2017 Mar 15;215(6):907-910. doi: 10.1093/infdis/jix029.

PMID:
28453835
2.

Insulin-Like Growth Factor Is Associated with Changes in Body Composition with Antiretroviral Therapy Initiation.

Erlandson KM, Fiorillo SP, Cardoso SW, Riviere C, Sanchez J, Hakim J, Kumarasamy N, Badal-Faesen S, Lalloo U, Kumwenda J, Campbell TB, Brown TT.

AIDS Res Hum Retroviruses. 2017 May 16. doi: 10.1089/AID.2016.0327. [Epub ahead of print]

PMID:
28403619
3.

Recommendations for the management of idiopathic pulmonary fibrosis in South Africa: a position statement of the South African Thoracic Society.

Koegelenberg CF, Ainslie GM, Dheda K, Allwood BW, Wong ML, Lalloo UG, Abdool-Gaffar MS, Khalfey H, Irusen EM.

J Thorac Dis. 2016 Dec;8(12):3711-3719. doi: 10.21037/jtd.2016.12.05. Review.

4.

TB/HIV pleurisy reduces Th17 lymphocyte proportion independent of the cytokine microenvironment.

Korb VC, Phulukdaree A, Lalloo UG, Chuturgoon AA, Moodley D.

Tuberculosis (Edinb). 2016 Jul;99:92-9. doi: 10.1016/j.tube.2016.05.001. Epub 2016 May 6.

PMID:
27450010
5.

HIV and COPD: a conspiracy of risk factors.

Lalloo UG, Pillay S, Mngqibisa R, Abdool-Gaffar S, Ambaram A.

Respirology. 2016 Oct;21(7):1166-72. doi: 10.1111/resp.12806. Epub 2016 May 30. Review.

6.

Management of pulmonary hypertension.

Essop MR, Galie N, Badesch DB, Lalloo U, Mahomed AG, Naidoo DP, Ntsekhe M, Williams PG.

S Afr Med J. 2015 Jun;105(6):437-9.

PMID:
26716153
7.

Frequency of Antiretroviral Resistance Mutations among Infants Exposed to Single-Dose Nevirapine and Short Course Maternal Antiretroviral Regimens: ACTG A5207.

Hitti J, Halvas EK, Zheng L, Panousis CG, Kabanda J, Taulo F, Kumarasamy N, Pape JW, Lalloo U, Sprenger H, Klingman KL, Chan ES, McMahon D, Mellors JW.

J AIDS Clin Res. 2014 Nov;5(11). pii: 371. Epub 2014 Nov 9.

8.

Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

INSIGHT START Study Group., Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, Avihingsanon A, Cooper DA, Fätkenheuer G, Llibre JM, Molina JM, Munderi P, Schechter M, Wood R, Klingman KL, Collins S, Lane HC, Phillips AN, Neaton JD.

N Engl J Med. 2015 Aug 27;373(9):795-807. doi: 10.1056/NEJMoa1506816. Epub 2015 Jul 20.

9.

Comparison of HBV-active HAART regimens in an HIV-HBV multinational cohort: outcomes through 144 weeks.

Thio CL, Smeaton L, Hollabaugh K, Saulynas M, Hwang H, Saravanan S, Kulkarni S, Hakim J, Nyirenda M, Iqbal HS, Lalloo UG, Campbell TB, Lockman S, Currier JS.

AIDS. 2015 Jun 19;29(10):1173-82. doi: 10.1097/QAD.0000000000000686.

10.

Pre-cART Elevation of CRP and CD4+ T-Cell Immune Activation Associated With HIV Clinical Progression in a Multinational Case-Cohort Study.

Balagopal A, Asmuth DM, Yang WT, Campbell TB, Gupte N, Smeaton L, Kanyama C, Grinsztejn B, Santos B, Supparatpinyo K, Badal-Faesen S, Lama JR, Lalloo UG, Zulu F, Pawar JS, Riviere C, Kumarasamy N, Hakim J, Li XD, Pollard RB, Semba RD, Thomas DL, Bollinger RC, Gupta A; ACTG PEARLS and NWCS 319 Study team..

J Acquir Immune Defic Syndr. 2015 Oct 1;70(2):163-71. doi: 10.1097/QAI.0000000000000696.

11.

Differences in antiretroviral safety and efficacy by sex in a multinational randomized clinical trial.

Firnhaber C, Smeaton LM, Grinsztejn B, Lalloo U, Faesen S, Samaneka W, Infante R, Rana A, Kumarasamy N, Hakim J, Campbell TB.

HIV Clin Trials. 2015 May-Jun;16(3):89-99. doi: 10.1179/1528433614Z.0000000013. Epub 2015 May 15.

12.

Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial.

Kantor R, Smeaton L, Vardhanabhuti S, Hudelson SE, Wallis CL, Tripathy S, Morgado MG, Saravanan S, Balakrishnan P, Reitsma M, Hart S, Mellors JW, Halvas E, Grinsztejn B, Hosseinipour MC, Kumwenda J, La Rosa A, Lalloo UG, Lama JR, Rassool M, Santos BR, Supparatpinyo K, Hakim J, Flanigan T, Kumarasamy N, Campbell TB, Eshleman SH; AIDS Clinical Trials Group (ACTG) A5175 Study Team..

Clin Infect Dis. 2015 May 15;60(10):1541-9. doi: 10.1093/cid/civ102. Epub 2015 Feb 13.

13.

HIV prevention counseling intervention delivered during routine clinical care reduces HIV risk behavior in HIV-infected South Africans receiving antiretroviral therapy: the Izindlela Zokuphila/Options for Health randomized trial.

Fisher JD, Cornman DH, Shuper PA, Christie S, Pillay S, Macdonald S, Ngcobo N, Amico KR, Lalloo U, Friedland G, Fisher WA; SA Options Team..

J Acquir Immune Defic Syndr. 2014 Dec 15;67(5):499-507. doi: 10.1097/QAI.0000000000000348.

14.

Short-course Bangladesh regimen for multidrug-resistant tuberculosis: a step in the right direction?

Lalloo UG.

Int J Tuberc Lung Dis. 2014 Oct;18(10):1137-8. doi: 10.5588/ijtld.14.0618. No abstract available.

PMID:
25216824
15.

Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis.

Mayosi BM, Ntsekhe M, Bosch J, Pandie S, Jung H, Gumedze F, Pogue J, Thabane L, Smieja M, Francis V, Joldersma L, Thomas KM, Thomas B, Awotedu AA, Magula NP, Naidoo DP, Damasceno A, Chitsa Banda A, Brown B, Manga P, Kirenga B, Mondo C, Mntla P, Tsitsi JM, Peters F, Essop MR, Russell JB, Hakim J, Matenga J, Barasa AF, Sani MU, Olunuga T, Ogah O, Ansa V, Aje A, Danbauchi S, Ojji D, Yusuf S; IMPI Trial Investigators..

N Engl J Med. 2014 Sep 18;371(12):1121-30. doi: 10.1056/NEJMoa1407380. Epub 2014 Sep 1.

16.

Psychosocial predictors of non-adherence and treatment failure in a large scale multi-national trial of antiretroviral therapy for HIV: data from the ACTG A5175/PEARLS trial.

Safren SA, Biello KB, Smeaton L, Mimiaga MJ, Walawander A, Lama JR, Rana A, Nyirenda M, Kayoyo VM, Samaneka W, Joglekar A, Celentano D, Martinez A, Remmert JE, Nair A, Lalloo UG, Kumarasamy N, Hakim J, Campbell TB; PEARLS (ACTG A5175) Study Team..

PLoS One. 2014 Aug 25;9(8):e104178. doi: 10.1371/journal.pone.0104178. eCollection 2014.

17.

A strategy for developing future academic leaders for South Africa in a resource-constrained environment.

Lalloo UG, Bobat RA, Pillay S, Wassenaar D.

Acad Med. 2014 Aug;89(8 Suppl):S55-9. doi: 10.1097/ACM.0000000000000354.

18.

Academic Medicine. Foreword.

Medical Education Partnership Initiative Principal Investigators..

Acad Med. 2014 Aug;89(8 Suppl):S1-2. doi: 10.1097/ACM.0000000000000357. No abstract available.

19.

Outcomes among HIV-1 infected individuals first starting antiretroviral therapy with concurrent active TB or other AIDS-defining disease.

Périssé AR, Smeaton L, Chen Y, La Rosa A, Walawander A, Nair A, Grinsztejn B, Santos B, Kanyama C, Hakim J, Nyirenda M, Kumarasamy N, Lalloo UG, Flanigan T, Campbell TB, Hughes MD; P E A R L S study team of the ACTG..

PLoS One. 2013 Dec 31;8(12):e83643. doi: 10.1371/journal.pone.0083643. eCollection 2013.

20.

HIV transmission risk behavior among HIV-positive patients receiving antiretroviral therapy in KwaZulu-Natal, South Africa.

Shuper PA, Kiene SM, Mahlase G, MacDonald S, Christie S, Cornman DH, Fisher WA, Greener R, Lalloo UG, Pillay S, van Loggerenberg F, Fisher JD.

AIDS Behav. 2014 Aug;18(8):1532-40. doi: 10.1007/s10461-013-0647-1.

Supplemental Content

Loading ...
Support Center